Table 1 Characteristics of the included study
Author (years) | Country | Study design | Sample sizes | Age (years) | Gender (M/F) | Prostheses types | Follow-up (months) | Study population | Outcomes |
|---|---|---|---|---|---|---|---|---|---|
slTSA/sTSA | slTSA/sTSA | slTSA/sTSA | slTSA/sTSA | slTSA/sTSA | |||||
Uschok et al. [15] | Germany | RCT | 20/20 | 65/69 | 10/10; 7/13 | Eclipse/Univers II | 60/60 | Primary glenohumeral OA | ①②③④⑤⑥ |
Glanzmann et al. [14] | Switzerland | CS | 37/37 | 64.4 ± 13/66.7 ± 11.7 | 9/28; 9/28 | Promos/Promos | 24/24 | Primary glenohumeral OA | ② |
Spranz et al. [13] | Germany | CS | 12/13 | 74.0 ± 5.7/71.0 ± 5.4 | 5/6; 4/5 | TESS/Aequalis | 51.6/75.6 | Primary glenohumeral OA | ①②③④⑤⑥ |
Moroder et al. [12[ | Austria | CS | 24/24 | 75.6 ± 4.6/74.3 ± 4.6 | 7/17; 7/17 | TESS/Delta Xtend | 34.2 ± 10.5/35.2 ± 14.6 | Cuff-tear arthropathy | ②③④ |
Maier et al. [11] | Germany | CS | 12/12 | 68.3 ± 5.4/67.8 ± 7.1 | 7/5; 3/9 | TESS/Aequalis | 6/6 | Primary glenohumeral OA | ①②③④⑤⑥ |
Mariotti et al. [10] | Italy | RCT | 9/10 | – | – | Aequalis/Aequalis | 24/24 | Primary concentric OA | ②③ |
Berth and Pap 2013 [3] | Germany | CS | 41/41 | 67.22 ± 9.0/67.05 ± 8.5 | 14/27; 14/27 | TESS/Affinis | 30.8 ± 4.6/32.7 ± 4.8 | Primary glenohumeral OA | ①②③④⑤⑥ |
Razmjou et al. [16] | Canada | PS | 17/18 | 69.0 ± 9.0/65.0 ± 11.0 | 8/9; 8/10 | TESS/Neer | 24/24 | Primary glenohumeral OA | ②③④ |